Koers Bioadaptives Inc OTC Bulletin Board
Aandelen
US09072U1079
Voedselverwerking
Omzet 2022 | 0,02 0,02 | Omzet 2023 | 0,03 0,03 | Marktkapitalisatie | 448K 412K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | 30.165.231 x |
Nettoschuld 2022 | 367K 337K | Nettoschuld 2023 | 268K 247K | EV/omzet 2023 | 25.075.337 x |
K/w-verhouding 2022 |
-0,07
x | K/w-verhouding 2023 |
-0,39
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 99,77% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Edward E. Jacobs
CEO | Chief Executive Officer | 83 | 15-03-18 |
Robert W. Ellis
DFI | Director of Finance/CFO | 82 | 11-09-19 |
Charles Townsend
COO | Chief Operating Officer | 78 | 31-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Edward E. Jacobs
CEO | Chief Executive Officer | 83 | 15-03-18 |
Robert W. Ellis
DFI | Director of Finance/CFO | 82 | 11-09-19 |
Charles Townsend
COO | Chief Operating Officer | 78 | 31-05-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,16% | 8,44 mld. | |
+3,57% | 7,47 mld. | |
+6,50% | 6,31 mld. | |
-4,70% | 3,77 mld. | |
-6,75% | 3,73 mld. | |
-3,55% | 1,33 mld. | |
+14,40% | 988 mln. | |
-9,25% | 927 mln. | |
-17,08% | 801 mln. |